ВЕТЕРИНАРИЯ. Ветеринарная медицина
C. of Vet. Sc. Firsov G.M., Kuntsevich A.N.,
Nistratova M.V.
Volgograd State Agricultural University, Russian
Federation
LABORATORY DIAGNOSIS OF AUTOIMMUNE
DISEASES.
Diseases,
pathogenesis of which immune response directed against normal tissue components
are major damaging factor, defined as an autoimmune disease.
In
connection with this problem it is worth noting that they make up 20% of all
systemic diseases and represent one of the major problems in the clinic of internal
diseases.
For
laboratory diagnosis of autoimmune diseases, prognosis and monitoring of
therapy used in the determination of autoantibodies against components of its
own tissues.
In some
cases autoantibodies are directly involved in the pathogenesis of the disease,
but in most cases they only indicate the presence of autoimmune diseases are
not always being sufficient to establish a diagnosis.
Currently,
the following definition is used autoantibodies rheumatoid factor, C-reactive
protein [1], antistreptolysin-O, antinuclear antibodies, antinuclear factor,
antibodies to native DNA, denatured DNA antibodies, anti-cardiac antibodies,
anti-phospholipid antibodies, antibodies to collagen.
Determination
of rheumatoid factor in the peripheral blood by ELISA is used for patients with
suspected rheumatoid arthritis to monitor and control the effectiveness of the
remedial measures. It was found that high levels of rheumatoid factor is
correlated with more severe rheumatoid arthritis and the presence of the system
(extra-articular) manifestations. Given the nature of the inflammation of
rheumatoid arthritis, for monitoring the disease and the effectiveness of
therapy in addition to the determination of rheumatoid factor expedient
quantitative determination of C-reactive protein.
Antinuclear
factor is a set of antibodies that react with different antigens of the cell
nucleus (DNA nucleotides histone, ribosomes, nucleoli).
Diagnostic
informativeness are the concentration and type of anti-nuclear factor.
Particularly
high antibody titers achieved antistreptolisin about an exacerbation of
glomerulonephritis. The greatest diagnostic and prognostic significance have
data about the level of anti-streptolysin O in the course of the disease
(definition approximately weekly intervals). Character changes titer
anti-streptolysin O or evidence of the success of antibiotic therapy, or the
persistence of the pathogen, even under favorable clinical dynamics.
C-reactive
protein is nonspecific for any particular disease, are not characteristic of
acute inflammation, and may indicate activity. Raising occurs not only against
infections, but also to inflammatory, autoimmune and allergic diseases.
The
level of C-reactive protein were not significantly increased during viral
infection and spirohetnoy. Successive determination of levels of C reactive
protein can be used to monitor the effectiveness of antimicrobial treatment. In
contrast to the widely used erythrocyte sedimentation rate test as a
nonspecific indicator sharpness process, C-reactive protein is more labile,
and, therefore, more convenient for clinical monitoring indicator. Furthermore,
the level of C-reactive protein unlike erythrocyte sedimentation rate,
regardless of sex, time of day, amount and morphology of the red blood cells,
plasma protein composition.
Antibodies
to the myocardium appear when myocarditis, idiopathic dilated cardiomyopathy
and rheumatic myocarditis. They can be used for diagnosis of these diseases,
but no titer reflects clinical activity.
Collagen
antibodies used for the detection of autoimmune diseases associated with the
overproduction of antibodies to different collagen types in order to determine
the extent and orientation of the predominant autoimmune process. Antibodies
are highly specific to collagen for rheumatoid arthritis and juvenile
rheumatoid. Antibodies to collagen correlated with the activity of auto-immune
diseases, are an indication of the effectiveness of the treatment (for a change
in titer).
Antibodies
to denatured DNA are the main components of most nuclear antibodies, however,
they are not specific with respect to certain diseases. It is expedient to use
the definition of antibodies to denatured DNA for the differential diagnosis of
lupus caused by drugs.
Bibliography:
1 David Stollar, Lawrence
Levine, Julius Marmur, Antibodies to denatured deoxyribonucleic acid in lupus
erythematosus serum II. Characterization of antibodies in several sera. Biochimica
et Biophysica Acta (BBA) - Specialized Section on Nucleic Acids and Related
Subjects Volume 61, Issue 1, 9 July 1962, Pages 7–18.